Mirum Pharmaceuticals Inc (MIRM) support and resistance · rev $336.1M
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
This page maps Mirum Pharmaceuticals Inc (MIRM) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.
MIRM currently screens at market cap $6.22B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new MIRM 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the MIRM quote page for the session range and the stock page for the full model.
Not investment advice.